Reduced Klotho is associated with the presence and severity of coronary artery disease

Heart

Volumn 100, Issue 1, 2014, Pages 34-40

  Navarro González, Juan F ^a   Donate Correa, Javier ^a   De Fuentes, Mercedes Muros ^a   Pérez Hernández, Horacio ^a   Martínez Sanz, Rafael ^b   Mora FernáNdez, Carmen ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; KLOTHO PROTEIN; MESSENGER RNA;

ADULT; AGE; AGED; ARTICLE; BLOOD VESSEL WALL; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING;

CORONARY ARTERY DISEASE;

AGED; AGING; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; GENE EXPRESSION REGULATION; GLUCURONIDASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA; SEVERITY OF ILLNESS INDEX;

EID: 84891771127     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304746     Document Type: Article

References (48)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
2. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation on the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997;390: 45-51. (Pubitemid 27494749)
3. Kuro-o M. Klotho. Pflügers Archiv. Eur J Physiol 2010;459: 333-43.
4. Lim K, Lu TS, Molostvov G, et al. Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to FGF-23. Circulation 2012;125: 2243-55.
5. Donate-Correa J, Mora-Fernández C, Martínez-Sanz R, et al. Expression of FGF23/ KLOTHO system in human vascular tissue. Int J Cardiol 2013;165: 179-83.
6. Matsumura Y, Aizawa H, Shiraki-Iida T, et al. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho proteins. Biochem Biophys Res Comm 1998;242: 626-30. (Pubitemid 28412578)
7. Chen TH, Kuro-O M, Chen CH, et al. The secreted klotho protein restores phosphate retention and suppresses accelerated aging in Klotho mutant mice. Eur J Pharmacol 2013;698: 67-73.
8. Kuro-o M. Klotho and the aging process. Korean J Intern Med 2011;26: 113-22.
9. Nagai R, Saito Y, Ohyama Y, et al. Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell Mol Life Sci 2000;57: 738-46. (Pubitemid 30392032)
10. Rakugi H, Matsukawa N, Ishikawa K, et al. Anti-oxidative effect of klotho on endothelial cells through cAMP activation. Endocrine 2007;31: 82-7. (Pubitemid 350194199)
11. Maekawa Y, Ohishi M, Ikushima M, et al. Klotho protein diminishes endothelial apoptosis and senescence via a mitogen-activated kinase pathway. Geriatr Gerontol Int 2011;11: 510-16.
12. Maekawa Y, Ishikawa K, Yasuda O, et al. Klotho suppresses TNF-alpha-induced expression of adhesión molecules in the endothelium and attenuates NF-kappaB activation. Endocrine 2009;35: 341-6.
13. Moe SM. Klotho: a master regulator of cardiovascular disease? Circulation 2012;125: 2181-3.
14. Ikushima M, Rakugi H, Ishikawa K, et al. Anti-apoptotic and anti-senescence effects of klotho on vascular endothelial cells. Biochem Biophys Res Commun 2006;339: 827-32. (Pubitemid 41772888)
15. Arking DE, Becker DM, Yanek LR, et al. KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am J Human Genet 2003;72: 1154-61. (Pubitemid 36530003)
16. Imamura A, Okumura K, Ogawa Y, et al. Klotho gene polymorphism may be a genetic risk factor for atherosclerotic coronary artery disease but not for vasospastic angina in Japanese. Clin Chim Acta 2006;371: 66-70. (Pubitemid 44162896)
17. Jo SH, Kim SG, Choi YJ, et al. Klotho gene polymorphism is associated with coronary artery stenosis but not with coronary calcification in a Korean Population. Int Heart J 2009;50: 23-32.
18. Semba RD, Cappola AR, Sun K, et al. Plasma klotho and cardiovascular disease in adults. J Am Geriatr Soc 2011;59: 1596-601.
19. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130: 461-70. (Pubitemid 29135798)
20. Patel MR, Dehmer GJ, Hirshfeld JW, et al. Appropriateness criteria for coronary revascularization: a report of the American College Of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American society of Nuclear Cardiology: endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. Circulation 2009;119:e488.
21. Yamazaki Y, Imura A, Urakawa I, et al. Establishment of sandwich ELISA for soluble alpha-Klotho measurement: age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun 2010;398: 513-18.
22. Heijboer AC, Blankenstein MA, Hoenderop J, et al. Laboratory aspects of circulating α-Klotho. Nephrol Dial Transplant 2013;28: 2283-7.
23. Siahanidou T, Garatzioti M, Lazaropoulou C, et al. Plasma soluble α-klotho protein levels in premature and term neonates: correlations with growth and metabolic parameters. Eur J Endocrinol 2012;167: 433-40.
24. Neidert MC, Sze L, Zwimpfer C, et al. Soluble α-klotho: a novel biomarker for the activity of GH-producing pituitary adenomas. Eur J Endocrinol 2013;168: 575-83.
25. Kitagawa M, Sugiyama H, Morinaga H, et al. A decreased level of serum soluble klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease. PLoS One 2013;8:e56695.
26. Lee J, Jeong DJ, Kim J, et al. The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma. Mol Cancer 2010;9:109.
27. Kusaba T, Okigaki M, Matui A, et al. Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity. Proc Natl Acad Sci USA 2010;107: 19308-13.
28. Saito Y, Yamagishi T, Nakamura T, et al. Klotho protein protects against endothelial dysfunction. Biochem Biophys Res Commun 1998;248: 324-9. (Pubitemid 28386420)
29. Huang CL. Regulation of ion channels by secreted klotho: mechanisms and implications. Kidney Int 2010;77: 855-60.
30. Chen CD, Podvin S, Gillespie E, et al. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci U S A 2007;104: 19796-801.
31. Oguro R, Kamide K, Kokubo Y, et al. Association of carotid atherosclerosis with genetic polymorphisms of the klotho gene in patients with hypertension. Geriatr Gerontol Int 2010;10: 311-18.
32. Arking DE, Atzmon G, Arking A, et al. Association between a functional variant of the KLOTHO gene and high-density lipoprotein, cholesterol, blood pressure, stroke and longevity. Cir Res 2005;96: 412-18. (Pubitemid 40354534)
33. Koh N, Fujimori T, Nishiguchi S, et al. Severely reduced production of klotho in human chronic renal failure. Biochem Biophys Res Commun 2001;280: 1015-20. (Pubitemid 32924441)
34. Hu MC, Shi M, Zhang J, et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011;22: 124-36.
35. Kendrick J, Chonchol M. The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis 2011;58: 826-34.
36. Takeda E, Taketani Y, Morita K, et al. Sodium-dependent phosphate co-transporters. Int J Biochem Cell Biol 1999;31: 377-81. (Pubitemid 29112898)
37. Li X, Yang H, Giachelli C. Role of sodium-dependent phosphate contransporter, Pit-1, in vascular smooth muscle cell calcification. Cir Res 2006;98: 905-12.
38. Crouthamel MH, Lau WL, Leaf EM, et al. Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2. Arterioscler Thromb Vasc Biol. Published Online First:22 Aug 2013.
39. Hu MC, Shi M, Zhang J, et al. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 2010;24: 3438-50.
40. Donate-Correa J, Muros de Fuentes M, Mora-Fernández C, et al. FGF23/Klotho axis: phosphorus, mineral metabolism and beyond. Cytokine Growth Factor Rev 2012;23: 37-46.
41. Shroff R, Shanahan CM. Klotho: an elixir of youth for the vasculature? J Am Soc Nephrol 2011;22: 1-3.
42. Shimada T, Takeshita Y, Murohara T, et al. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 2004;110: 1148-55. (Pubitemid 39328204)
43. Kusaba T, Okigaki M, Matui A, et al. Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity. Proc Natl Acad Sci USA 2010;107: 19308-13.
44. Liu F, Wu S, Ren H, et al. Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat Cell Biol 2011;13: 254-62.
45. Wang Y, Kuro-O M, Sun Z. Klotho gene delivery suppresses Nox2 expression and attenuates oxidative stress in rat aortic smooth muscle cells via the cAMP-PKA pathway. Aging Cells 2012;11: 410-17.
46. Ohyama Y, Kurabayashi M, Masuda H, et al. Molecular cloning of rat klotho cDNA: markedly decreased expression of klotho by acute inflammatory stress. Biochem Biophys Res Commun 1998;251: 920-5. (Pubitemid 28512812)
47. Thurston RD, Larmonier CB, Majewski PM, et al. Tumor necrosis factor and interferon-gamma down-regulate klotho in mice with colitis. Gastroenterology 2010;138: 1384-94.
48. Moreno JA, Izquierdo MC, Sanchez-Niño MD, et al. The inflammatory cytokines TWEAK and TNF-alpha reduce renal klotho expression through NFKappaB. J Am Soc Nephrol 2011;22: 1315-25.